Chart, page-5827

Why were the likes of these people not approached for funding or at least a first port of call so to speak

https://www.cureduchenne.org/ventures/

I noticed they supported pepgens ipo

With the financing, a syndicate of new investors joins PepGen‘s existing backers RA Capital Management, Oxford Sciences Innovation (OSI), and CureDuchenne Ventures.

also

CDV is also often a valued syndicate partner at seed and Series A funding rounds, where, in addition to capital, we provide expertise for de-risking DMD projects towards key inflection points. All of this is critical for cultivating more “shots on goal” in terms of DMD therapies. CDV has funded more than 44 projects designed to target various aspects of the disease process, and our efforts have leveraged nearly $3 billion in follow-on investments in DMD from venture capital, biotech and pharma companies.  Importantly, our investment in new and transformative technologies illustrates our desire to think differently and put patients first.

https://www.cellandgene.com/doc/venture-philanthropy-for-duchenne-muscular-dystrophy-0001

So what if you have to give a little bit more away to the likes of CDV at least the fund is going back to a good cause, and not only that get your foot in the door and they are connected,  look at their connections

it really is so sad how this has panned out